Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR database
Publication date: November 2026 Source: European Journal of Internal Medicine, Volume 153 Author(s): Blaž Burja, Marouane Boubaya, Cosimo Bruni, Lisa Christ, Lidia P. Ananyeva, Fabiola Atzeni, Christina Bergmann, Patricia E. Carreira, Jeska De Vries-Bouwstra, Nicoletta Del Papa, Antonella Marcoccia, Okada Masado, Gabriela Riemekasten, Edoardo Rosato, Tim Schmeiser, Marco Sprecher, Anna-Maria Hoffmann-Vold, Florian Kollert, Sabina Guler, Oliver Distler
Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR database. // European Journal of Internal Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S0953620526002037?dgcid=rss_sd_all
Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR database. European Journal of Internal Medicine. https://www.sciencedirect.com/science/article/pii/S0953620526002037?dgcid=rss_sd_all
“Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR database.” European Journal of Internal Medicine.
@article{article45573,
title = {Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR database},
journal = {European Journal of Internal Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S0953620526002037?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...